NCT00239798View on ClinicalTrials.gov

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

255

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

November 30, 2006

Conditions
Renal Transplantation
Interventions
DRUG

FTY720

Sponsors
All Listed Sponsors
collaborator

Mitsubishi Tanabe Pharma Corporation

INDUSTRY

lead

Novartis Pharmaceuticals

INDUSTRY